by Andrew Khouri | Apr 12, 2023 | News
~ New Data will be Presented on the Company’s Innovative Assay Technologies, Preclinical Profiling Models and Proprietary Screening Platforms ~ ~ Reaction Biology will be at Booth #1527 in the AACR 2023 Exhibit Hall ~ Malvern, PA – April 12, 2023 – Reaction Biology...
by Andrew Khouri | Dec 19, 2022 | News
Malvern, PA, December 19, 2022 – Reaction Biology Corporation (“Reaction”), an industry-leading provider of drug discovery services, today announced that it has been selected to participate as a Specialized Center in the Chemical Biology Consortium (CBC), the...
by Andrew Khouri | Dec 2, 2022 | News
~ Bioassay GmbH, an Independent Contract Laboratory, Specializes in the Development, Validation and Routine Performance of Bioanalytical Assays ~ ~ Transaction Includes Acquisition of Bioassay GmbH Subsidiary, Peptide Specialty Laboratories GmbH, a Provider...
by Andrew Khouri | Nov 3, 2022 | News
~ Reaction Biology Acquires the Hershey, Pennsylvania-Based U.S. Operations of Vyant Bio Subsidiary vivoPharm PTY Ltd ~ ~ Transaction Expands Reaction Biology’s Capabilities to Provide Customers with Solutions in Both the Discovery and Development of New Drug...
by Andrew Khouri | May 11, 2022 | Blog
Reaction’s Assay Formats The NanoBRET Intracellular Target Engagement Assay technology enables the investigation of compound-target engagement (or binding) in the physiological environment of intact cells. NanoBRET is an energy transfer technique designed to measure...
